Blood eosinophil counts could be used to guide reductions in systemic corticosteroid dosing in patients with acute exacerbations of COPD without compromising outcomes, a Danish study has shown. A randomised, open-label trial in 358 patients hospitalised with acute exacerbations showed that use of eosinophil-guided corticosteroid therapy reduced steroid duration from five days to two days ...
Eosinophil-guided therapy reduces steroids in COPD exacerbations
By Michael Woodhead
21 May 2019